Berliner Boersenzeitung - Who should get paid for nature's sequenced genes?

EUR -
AED 4.308166
AFN 77.493513
ALL 96.416224
AMD 447.045299
ANG 2.099893
AOA 1075.722267
ARS 1685.120948
AUD 1.758201
AWG 2.114493
AZN 2.015681
BAM 1.955123
BBD 2.358374
BDT 143.090483
BGN 1.954604
BHD 0.442184
BIF 3460.702414
BMD 1.173089
BND 1.514582
BOB 8.0912
BRL 6.345356
BSD 1.17089
BTN 105.690426
BWP 16.52821
BYN 3.435511
BYR 22992.545367
BZD 2.354975
CAD 1.614182
CDF 2621.853787
CHF 0.932647
CLF 0.027339
CLP 1072.497336
CNY 8.279721
CNH 8.273782
COP 4461.550927
CRC 583.100702
CUC 1.173089
CUP 31.08686
CVE 110.226856
CZK 24.227281
DJF 208.506957
DKK 7.469492
DOP 74.984371
DZD 152.147275
EGP 55.776628
ERN 17.596336
ETB 182.33418
FJD 2.665025
FKP 0.873747
GBP 0.876761
GEL 3.168098
GGP 0.873747
GHS 13.442348
GIP 0.873747
GMD 85.635638
GNF 10184.475634
GTQ 8.967897
GYD 244.935239
HKD 9.132281
HNL 30.827463
HRK 7.53299
HTG 153.345627
HUF 383.263446
IDR 19527.240315
ILS 3.753586
IMP 0.873747
INR 106.019684
IQD 1533.8692
IRR 49398.779765
ISK 148.207447
JEP 0.873747
JMD 187.594283
JOD 0.831683
JPY 182.756739
KES 150.999865
KGS 102.586892
KHR 4687.357948
KMF 492.697066
KPW 1055.775722
KRW 1731.561527
KWD 0.35981
KYD 0.975762
KZT 609.699012
LAK 25396.211572
LBP 104855.914324
LKR 362.104693
LRD 206.668482
LSL 19.829938
LTL 3.463827
LVL 0.70959
LYD 6.359772
MAD 10.770773
MDL 19.941099
MGA 5193.180751
MKD 61.566496
MMK 2463.801609
MNT 4161.388658
MOP 9.385052
MRU 46.416135
MUR 53.868474
MVR 18.077138
MWK 2030.388724
MXN 21.13483
MYR 4.797618
MZN 74.982217
NAD 19.829938
NGN 1700.592086
NIO 43.08509
NOK 11.824374
NPR 169.105201
NZD 2.016776
OMR 0.451054
PAB 1.170895
PEN 3.946434
PGK 4.96826
PHP 69.283242
PKR 329.319834
PLN 4.22776
PYG 8002.196711
QAR 4.267523
RON 5.090849
RSD 117.401581
RUB 93.700505
RWF 1704.302957
SAR 4.401882
SBD 9.655217
SCR 15.985985
SDG 705.628143
SEK 10.874453
SGD 1.514933
SHP 0.880121
SLE 28.255969
SLL 24599.088637
SOS 667.966001
SRD 45.26657
STD 24280.574864
STN 24.49142
SVC 10.245455
SYP 12972.465321
SZL 19.824055
THB 37.091875
TJS 10.795864
TMT 4.105812
TND 3.433212
TOP 2.824517
TRY 50.083471
TTD 7.94625
TWD 36.613871
TZS 2885.784946
UAH 49.424286
UGX 4163.559189
USD 1.173089
UYU 46.104046
UZS 14075.129263
VES 310.557571
VND 30859.280532
VUV 142.514088
WST 3.265817
XAF 655.727289
XAG 0.018305
XAU 0.000272
XCD 3.170332
XCG 2.11027
XDR 0.815514
XOF 655.727289
XPF 119.331742
YER 279.635057
ZAR 19.756169
ZMK 10559.204028
ZMW 26.843596
ZWL 377.734195
  • SCS

    0.0200

    16.14

    +0.12%

  • RBGPF

    0.0000

    81.17

    0%

  • CMSC

    0.1300

    23.43

    +0.55%

  • BCC

    -0.7500

    76.26

    -0.98%

  • CMSD

    0.1200

    23.4

    +0.51%

  • RIO

    0.5000

    76.74

    +0.65%

  • GSK

    0.4700

    48.88

    +0.96%

  • RYCEF

    -0.1000

    14.64

    -0.68%

  • BCE

    0.2100

    23.4

    +0.9%

  • BTI

    -0.3900

    58.37

    -0.67%

  • NGG

    0.0500

    74.69

    +0.07%

  • RELX

    0.2000

    40.28

    +0.5%

  • JRI

    0.0000

    13.72

    0%

  • BP

    -0.3500

    35.53

    -0.99%

  • AZN

    -1.2200

    90.29

    -1.35%

  • VOD

    -0.0200

    12.54

    -0.16%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

(K.Müller--BBZ)